Molecular mechanisms of action and physiological effects of the proinsulin C-peptide (a systematic review)

2020 ◽  
Vol 66 (3) ◽  
pp. 196-207
Author(s):  
O.N. Poteryaeva ◽  
I.F. Usynin

The C-peptide is a fragment of proinsulin, the cleavage of which forms active insulin. In recent years, new information has appeared on the physiological effects of the C-peptide, indicating its positive effect on many organs and tissues, including the kidneys, nervous system, heart, vascular endothelium and blood microcirculation. Studies on experimental models of diabetes mellitus in animals, as well as clinical trials in patients with diabetes, have shown that the C-peptide has an important regulatory effect on the early stages of functional and structural disorders caused by this disease. The C-peptide exhibits its effects through binding to a specific receptor on the cell membrane and activation of downstream signaling pathways. Intracellular signaling involves G-proteins and Ca2+-dependent pathways, resulting in activation and increased expression of endothelial nitric oxide synthase, Na+/K+-ATPase and important transcription factors involved in apoptosis, anti-inflammatory and other intracellular defense mechanisms. This review gives an idea of the C-peptide as a bioactive endogenous peptide that has its own biological activity and therapeutic potential.

Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2869
Author(s):  
Maria Michela Cesare ◽  
Francesca Felice ◽  
Veronica Santini ◽  
Rossella Di Stefano

The decline of skeletal muscle mass and strength that leads to sarcopenia is a pathology that might represent an emergency healthcare issue in future years. Decreased muscle mass is also a condition that mainly affects master athletes involved in endurance physical activities. Skeletal muscles respond to exercise by reshaping the biochemical, morphological, and physiological state of myofibrils. Adaptive responses involve the activation of intracellular signaling pathways and genetic reprogramming, causing alterations in contractile properties, metabolic status, and muscle mass. One of the mechanisms leading to sarcopenia is an increase in reactive oxygen and nitrogen species levels and a reduction in enzymatic antioxidant protection. The present review shows the recent experimental models of sarcopenia that explore molecular mechanisms. Furthermore, the clinical aspect of sport sarcopenia will be highlighted, and new strategies based on nutritional supplements, which may contribute to reducing indices of oxidative stress by reinforcing natural endogenous protection, will be suggested.


2010 ◽  
Vol 391 (9) ◽  
Author(s):  
John T. Heiker ◽  
David Kosel ◽  
Annette G. Beck-Sickinger

Abstract The adipocytokine adiponectin and its receptor (AdipoR) comprise a new receptor-ligand system that is involved in a variety of clinically important morbidities such as obesity, type 2 diabetes and cardiovascular diseases. Adiponectin exerts a multitude of beneficial and tissue specific effects depending on its unique, tightly regulated multimerization behavior. Post-translational modifications are essential for the multimer assembly before secretion and protein stability in the circulation. AdipoR1 and 2 have been discovered as a new class of heptahelix receptors structurally and functionally distinct from G-protein-coupled receptors. Both AdipoRs bind adiponectin and the downstream signaling of both AdipoRs is mediated mainly by phosphorylation of AMPK and activation of peroxisome proliferator-activated receptor α, which influence the lipid and glucose metabolism of skeletal muscle and liver cells as well as inflammatory processes and vascular endothelial integrity. Several intracellular binding partners of the AdipoR N-terminus such as APPL1, CK2β and ERp46 have been identified and shown to control receptor signaling. Adiponectin has also been reported to modulate the dimerization and internalization of AdipoRs, which provides new insights into the molecular characteristics of this unusual receptor. The understanding of the functional mechanisms of adiponectin signal transduction is critical to benefit from the full therapeutic potential of the adiponectin-AdipoR system.


2020 ◽  
Author(s):  
Veronique Proux-Gillardeaux ◽  
Tamara Advedissian ◽  
Charlotte Perin ◽  
Jean-Christophe Gelly ◽  
Mireille Viguier ◽  
...  

ABSTRACTEGFR plays key roles in multiple cellular processes such as cell differentiation, cell proliferation, migration and epithelia homeostasis. Phosphorylation of the receptor, intracellular signaling and trafficking are major events regulating EGFR functions. Galectin-7, a soluble lectin expressed in epithelia such as the skin, has been shown to be involved in cell differentiation. Through this study we demonstrate that galectin-7 regulates EGFR function by a direct interaction with its extracellular domain hence modifying its downstream signaling and endocytic pathway. From observations in mice we focused on the molecular mechanisms deciphering the glycosylation dependent interaction between EGFR and galectin-7. Interestingly, we also revealed that galectin-7 is a direct binder of both EGFR and E-cadherin bridging them together. Strikingly this study not only deciphers a new molecular mechanism of EGFR regulation but also points out a novel molecular interaction between EGFR and E-cadherin, two major regulators of the balance between proliferation and differentiation.SUMMARYEGFR and E-cadherin are known to interact and to regulate epithelial homeostasis. In this study we unravel in the epidermis a new partner and regulator of EGFR which also binds E-cadherin reciprocally bridging their dynamics and functions.


2019 ◽  
Vol 2019 ◽  
pp. 1-14 ◽  
Author(s):  
Athanasia Pavlopoulou ◽  
Ezgi Karaca ◽  
Alma Balestrazzi ◽  
Alexandros G. Georgakilas

The plant innate immune system has two major branches, the pathogen-triggered immunity and the effector-triggered immunity (ETI). The effectors are molecules released by plant attackers to evade host immunity. In addition to the foreign intruders, plants possess endogenous instigators produced in response to general cellular injury termed as damage-associated molecular patterns (DAMPs). In plants, DAMPs or alarmins are released by damaged, stressed, or dying cells following abiotic stress such as radiation, oxidative and drought stresses. In turn, a cascade of downstream signaling events is initiated leading to the upregulation of defense or response-related genes. In the present study, we have investigated more thoroughly the conservation status of the molecular mechanisms implicated in the danger signaling primarily in plants. Towards this direction, we have performed in silico phylogenetic and structural analyses of the associated biomolecules in taxonomically diverse plant species. On the basis of our results, the defense mechanisms appear to be largely conserved within the plant kingdom. Of note, the sequence and/or function of several components of these mechanisms was found to be conserved in animals, as well. At the same time, the molecules involved in plant defense were found to form a dense protein-protein interaction (PPi) network, suggesting a crosstalk between the various defense mechanisms to a variety of stresses, like oxidative stress.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 3460-3460
Author(s):  
Markus Bosmann ◽  
Julian Roewe ◽  
Dennis Riehl ◽  
Matthias Theobald ◽  
Peter A. Ward

Abstract The central nervous system has the ability for modulating immune responses, but the molecular mechanisms of such interactions are only partly understood. Interleukin-27 (IL-27) is a heterodimeric protein and structurally related to the IL-12 family of cytokines. IL-27 is composed of the subunits EBI3 and p28. The biological functions of IL-27 have been described as either anti-inflammatory or pro-inflammatory depending on the experimental models studied. In the current study, we investigated how production of Interleukin-27 (IL-27) is regulated by neuroendocrine hormones. We focused our work on the subunit p28, since EBI3 is also present in IL-35 and therefore is not a specific component of IL-27. First, we used F4/80+CD11b+ macrophages from C57BL/6J mice derived either from the bone marrow (BMDM) or elicited by intra-peritoneal injection of thioglycollate (PEM). IL-27 was abundantly expressed and secreted in cultures of macrophages (PEM and BMDM) when these cells were activated by lipopolysaccharide (LPS). The addition of neuroendocrine hormones of the sympathetic nervous system (adrenaline and noradrenaline) greatly reduced the capacity of LPS-activated macrophages to generate IL-27p28 at all time points studied (0-24 h; Fig. 1A, 1B). The effects of these catecholamines were dose-dependent over a range of 1 µM – 0.01 µM. To study the intracellular signaling events related to suppression of IL-27p28 by neuroendocrine hormones, we used bead-based multiplexing assays with antibodies specific for phosphorylated signaling proteins (Akt, c-Jun, CREB, ERK1/2, JNK, MEK1, NFκB, p38 MAPK, STAT3). Activation of macrophages with LPS within 20-60 min induced a 3-5-fold increase in phosphorylation of multiple signaling pathways including c-Jun N-terminal kinases (JNK) at threonine-183/tyrosine-185. Treatment of macrophages with adrenaline or noradrenaline greatly reduced phosphorylation of JNK following LPS. Inhibition of JNK-signaling using the small molecule inhibitor, SP600125, reduced the release of IL-27p28 from macrophages. This suggested that neuroendocrine hormones (adrenaline, noradrenaline) modulate IL-27p28-dependent immune responses via a JNK-dependent mechanism. To investigate the relevance of our findings regarding neuroendocrine regulation of IL-27p28 during acute inflammation, we used a model of endotoxic shock induced by intra-peritoneal injection of LPS (10 mg/kg body weight). Mice with genetic deficiency of the IL-27 receptor (IL-27RA-/-, WSX-1-/-) were significantly protected following endotoxic shock as compared to wild type control mice. These data suggest that IL-27 signaling promotes lethal outcomes of endotoxic shock. To further characterize the role of catecholamines, C57BL/6J mice underwent surgical removal of the adrenal glands for interrupting the secretion of adrenaline, noradrenaline and glucocorticoids. When adrenalectomized mice were subjected to endotoxic shock, these animals displayed 2-3-fold higher concentrations of IL-27p28 in plasma after 8 h. This observation may not only be explained by reduced concentrations of catecholamines in adrenalectomized mice, but also by a disruption of the pituitary-adrenal axis, since glucocorticoids in vitro also suppressed IL-27p28. In summary, these data describe novel interactions of endocrine transmitters of the nervous system and macrophage-derived IL-27. The hyperproduction of IL-27 observed in adrenalectomized mice provides a new explanation for the known susceptibility of such animals in experimental models of sepsis and other acute inflammatory diseases. Disclosures: No relevant conflicts of interest to declare.


2013 ◽  
Vol 305 (6) ◽  
pp. H779-H792 ◽  
Author(s):  
Melissa E. Reichelt ◽  
Kimberley M. Mellor ◽  
James R. Bell ◽  
Chanchal Chandramouli ◽  
John P. Headrick ◽  
...  

More than three decades ago, the Framingham study revealed that cardiovascular risk is elevated for all diabetics and that this jeopardy is substantially accentuated for women in particular. Numerous studies have subsequently documented worsened cardiac outcomes for women. Given that estrogen and insulin exert major regulatory effects through common intracellular signaling pathways prominent in maintenance of cardiomyocyte function, a sex-hormone:diabetic-disease interaction is plausible. Underlying aspects of female cardiovascular pathophysiology that exaggerate cardiovascular diabetic risk may be identified, including increased vulnerability to coronary microvascular disease, age-dependent impairment of insulin-sensitivity, and differential susceptibility to hyperglycemia. Since Framingham, considerable progress has been made in the development of experimental models of diabetic disease states, including a diversity of genetic rodent models. Ample evidence indicates that animal models of both type 1 and 2 diabetes variably recapitulate aspects of diabetic cardiomyopathy including diastolic and systolic dysfunction, and cardiac structural pathology including fibrosis, loss of compliance, and in some instances ventricular hypertrophy. Perplexingly, little of this work has explored the relevance and mechanisms of sexual dimorphism in diabetic cardiomyopathy. Only a small number of experimental studies have addressed this question, yet the prospects for gaining important mechanistic insights from further experimental enquiry are considerable. The case for experimental interrogation of sex differences, and of sex steroid influences in the aetiology of diabetic cardiomyopathy, is particularly compelling—providing incentive for future investigation with ultimate therapeutic potential.


2021 ◽  
Vol 2021 ◽  
pp. 1-18
Author(s):  
Daniela Gradinaru ◽  
Anca Ungurianu ◽  
Denisa Margina ◽  
Maria Moreno-Villanueva ◽  
Alexander Bürkle

Since its discovery in 1905 and its employment in everyday medical practice as a local anesthetic, to its highly controversial endorsement as an “anti-aging” molecule in the sixties and seventies, procaine is part of the history of medicine and gerontoprophylaxis. Procaine can be considered a “veteran” drug due to its long-time use in clinical practice, but is also a molecule which continues to incite interest, revealing new biological and pharmacological effects within novel experimental approaches. Therefore, this review is aimed at exploring and systematizing recent data on the biochemical, cellular, and molecular mechanisms involved in the antioxidant and potential geroprotective effects of procaine, focusing on the following aspects: (1) the research state-of-the-art, through an objective examination of scientific literature within the last 30 years, describing the positive, as well as the negative reports; (2) the experimental data supporting the beneficial effects of procaine in preventing or alleviating age-related pathology; and (3) the multifactorial pathways procaine impacts oxidative stress, inflammation, atherogenesis, cerebral age-related pathology, DNA damage, and methylation. According to reviewed data, procaine displayed antioxidant and cytoprotective actions in experimental models of myocardial ischemia/reperfusion injury, lipoprotein oxidation, endothelial-dependent vasorelaxation, inflammation, sepsis, intoxication, ionizing irradiation, cancer, and neurodegeneration. This analysis painted a complex pharmacological profile of procaine: a molecule that has not yet fully expressed its therapeutic potential in the treatment and prevention of aging-associated diseases. The numerous recent reports found demonstrate the rising interest in researching the multiple actions of procaine regulating key processes involved in cellular senescence. Its beneficial effects on cell/tissue functions and metabolism could designate procaine as a valuable candidate for the well-established Geroprotectors database.


Author(s):  
Hannah L. M. Spencer ◽  
Steven D. Shnyder ◽  
Paul M. Loadman ◽  
Robert A. Falconer

The dysregulation of Membrane - type 1 matrix metalloproteinase (MT1-MMP) has been extensively studied in numerous cancer types, and plays key roles in angiogenesis, cancer progression, and metastasis. MT1-MMP is a predictor of poor prognosis in osteosarcoma (OS), yet the molecular mechanisms of disease progression are unclear. This review provides a summary of the literature relating to the gene and protein expression of MT1-MMP (MMP-14) in OS clinical samples, evaluates the expression in cell lines and experimental models, and analyses its potential role in the progression and metastasis of OS. In addition, the therapeutic potential of MT1-MMP as a drug target has been assessed. Due to the biological complexity of MMPs, inhibition has proven to be challenging. However, exploiting the expression and proteolytic capacity of MT1-MMP could open new avenues in the search for novel, safer and selective drugs for use in OS.


2014 ◽  
Vol 307 (11) ◽  
pp. E955-E968 ◽  
Author(s):  
Gina L. C. Yosten ◽  
Christine Maric-Bilkan ◽  
Patrizia Luppi ◽  
John Wahren

Connecting Peptide, or C-peptide, is a product of the insulin prohormone, and is released with and in amounts equimolar to those of insulin. While it was once thought that C-peptide was biologically inert and had little biological significance beyond its role in the proper folding of insulin, it is now known that C-peptide binds specifically to the cell membranes of a variety of tissues and initiates specific intracellular signaling cascades that are pertussis toxin sensitive. Although it is now clear that C-peptide is a biologically active molecule, controversy still remains as to the physiological significance of the peptide. Interestingly, C-peptide appears to reverse the deleterious effects of high glucose in some tissues, including the kidney, the peripheral nerves, and the vasculature. C-peptide is thus a potential therapeutic agent for the treatment of diabetes-associated long-term complications. This review addresses the possible physiologically relevant roles of C-peptide in both normal and disease states and discusses the effects of the peptide on sensory nerve, renal, and vascular function. Furthermore, we highlight the intracellular effects of the peptide and present novel strategies for the determination of the C-peptide receptor(s). Finally, a hypothesis is offered concerning the relationship between C-peptide and the development of microvascular complications of diabetes.


Sign in / Sign up

Export Citation Format

Share Document